Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis (BEST)
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 1960 participants.
Also called NCT05454150
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,960 participants
- Sponsor
- Registry
-
NCT05454150
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05454150. Randomized; no masking; primary purpose treatment. Start 2023-04-19 (actual); primary completion 2025-10-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis (BEST)
- Acronym
- BEST
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- balloon-expandable valve
- Intervention (Device)
- self-expanding valve
- Lead sponsor
- University Hospital, Lille
- Collaborator
- Ministry of Health, France
- Collaborator
- Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Record details
- Record id
cardio:ct-nct05454150- Content hash
19cd736a8bb4f3bfec224090c4e2ae44084944202c5e5652e8ac857d1e9c57e4